TICKERNERD
Menu
UTMDUTMDHealthcare · Medical Instruments & Supplies

UTMD Stock Forecast: Utah Medical Products, Inc. Price Predictions for 2026-2027

Last close, 26 Aug 2026
$71
−0.10% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 78 of 100 as at 25 Aug 2026 — inside the top quartile.

Market cap
$225.9M
Ticker Nerd rank
78 / 100
Median analyst target
—
Analysts covering
0
Revenue$8.7M−10.2% y/y
Operating income$3.0M
Net income$2.6M
Free cash flow$3.0M
Quarterly, 7 quarters to 31 Mar 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−1.7%
1M
+5.6%
YTD
+27.9%
1Y
+19.1%
From 52W high
−4.2%
From 52W low
+33.8%
$53
$74
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

UTMD stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Utah Medical Products, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 25 Aug 2026
78 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
96
Momentum
86
Issuance
85
Value
79
Size
67
Quality
62
Accruals
50
Growth
49
Revisions
25

Volatility (96): The share price has been relatively steady.

Revisions (25): Analysts have, on balance, been cutting their forecasts.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

UTMD stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on UTMD, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$50$55$60$65$70$75Oct 25Jan 26Apr 26Jul 26UTMD

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. UTMD appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

UTMD vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 26 Aug 2026, Utah Medical Products, Inc. returned +19.1% against +20.1% for the S&P 500, dividends included.

UTMD vs S&P 500, last 12 monthsTotal return, rebased to 100
90100110120Oct 25Jan 26Apr 26Jul 26UTMDS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

UTMD analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Utah Medical Products, Inc. (UTMD) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
21.9×

Cheaper than 36% of US stocks

Price / sales
6.3×

Cheaper than 21% of US stocks

Price / book
1.9×

Cheaper than 49% of US stocks

EV / EBITDA
9.6×

Cheaper than 39% of US stocks

Growth & margins
Revenue growth (YoY)
−14.3%

Higher than 13% of US stocks

Earnings growth (YoY)
−11.9%

Higher than 25% of US stocks

Gross margin
60.6%

Higher than 74% of US stocks

Operating margin
36.9%

Higher than 90% of US stocks

Net margin
29.0%

Higher than 88% of US stocks

Returns & dividend
Return on equity
8.8%

Higher than 60% of US stocks

Return on assets
6.1%

Higher than 81% of US stocks

Dividend yield
1.8%

Higher than 40% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Utah Medical Products, Inc. (UTMD) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Utah Medical Products, Inc. has a market value of $225.9M and an enterprise value of $138.6M.

  • Revenue in the twelve months to 31 Mar 2026: $37.5M. The latest quarter shrank 14.3% year on year.

  • Net income over the same four quarters: $10.8M, a 28.9% net margin.

  • Diluted earnings per share, trailing twelve months: $3.38.

  • Free cash flow in the twelve months to 31 Mar 2026: $13.0M, after $54K of capital spending.

  • Utah Medical Products, Inc. spent $5.3M on share buybacks and $4.0M on dividends in the twelve months to 31 Mar 2026.

  • Shares outstanding: 3.2M.

  • Trailing P/E: 21.9×.

  • Forward dividend yield: 1.75%, paying out 38% of earnings.

  • Utah Medical Products, Inc. employs 140 people — $268K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 31 Mar 2026 · market figures as at 26 Aug 2026

Data provided by Twelve Data

Peers

UTMD vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Instruments & Supplies
CompanyMarket capTKN rank
UTMDUtah Medical Products, Inc.$225.9M
78
PDEXPro-Dex, Inc.$208.2M
87
ZJYLJin Medical International Ltd.$206.8M
15
OSUROraSure Technologies, Inc.$261.3M
87
EMBCEmbecta Corp.$297.9M
84
SMTISanara MedTech, Inc.$308.6M
90
KRMDKORU Medical Systems, Inc.$147.4M
96

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Utah Medical Products, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest UTMD news & analysis

Utah Medical Products, Inc. Announces Quarterly Dividend

Accesswire · 4 Aug 2026positive

Utah Medical Products announced that its Board of Directors approved a quarterly cash dividend of $0.31 per share, payable October 5, 2026 to stockholders of record on September 17, 2026. The dividend represents a 1.6% increase over the dividend declared in the same quarter of the prior year.

Why it matters — A UTMD watcher would care because the company maintained its shareholder payout with a year-over-year increase in the declared quarterly dividend.

Utah Medical's Q2 Earnings Down Y/Y Due to Customer Losses

Zacks Investment Research · 29 July 2026negative

Utah Medical Products reported Q2 earnings per share down 10.1% year over year, with quarterly revenues facing pressure from lost customers and slower new business growth.

Why it matters — This signals potential headwinds to UTMD's revenue and earnings momentum, which could affect the company's financial performance and shareholder returns.

FAQ

Frequently asked questions about UTMD stock

How does Ticker Nerd's model rank UTMD?

As at 25 Aug 2026, Utah Medical Products, Inc. ranks 78 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (96 of 100).

What is the UTMD stock forecast for 2030?

No analyst covering Utah Medical Products, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for UTMD are extrapolating price history, which says nothing about the business.

How has UTMD stock performed over the past year?

Utah Medical Products, Inc. returned +19.1% over the 12 months to 26 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Utah Medical Products, Inc. do?

Utah Medical Products, Inc. is a medical device company that develops, manufactures, and markets specialized disposable and reusable products for healthcare settings.

What is the latest news on UTMD?

The most recent item we track (Accesswire, 4 Aug 2026): "Utah Medical Products, Inc. Announces Quarterly Dividend". Utah Medical Products announced that its Board of Directors approved a quarterly cash dividend of $0.31 per share, payable October 5, 2026 to stockholders of record on September 17, 2026. The dividend represents a 1.6% increase over the dividend declared in the same quarter of the prior year.

Company

About Utah Medical Products, Inc.

Utah Medical Products, Inc. is a medical device company that develops, manufactures, and markets specialized disposable and reusable products for healthcare settings. The company focuses on women’s and babies’ health, with offerings used in obstetrics, gynecology, neonatal care, perinatology, urology, blood pressure monitoring, and blood collection. Its product portfolio includes labor and delivery tools, fetal monitoring accessories, vacuum-assisted delivery systems, infant respiratory hoods, and electrosurgical devices. Utah Medical Products serves hospitals, clinics, and other medical facilities that require procedure-specific devices designed for clinical use and patient safety. Headquartered in Midvale, Utah, the company operates as a focused supplier within the broader medical instruments and supplies market, with products distributed across domestic and international healthcare markets.

CEO Mr. Kevin L. Cornwell · 140 employees · United States · https://www.utahmed.com